Logo HORAMA

Activités

Breakthrough biotechnology developing gene therapy targeting genetic & rare retinopathies.

Produits et services

Horama holds a wide portfolio of products in development such as HORA-RPE65 that demonstrated promising clinical results in treating Leber congenital amaurosis and HORA-PDE6B entering the clinic early 2017 in Retinitis Pigmentosa.

Contact

  • Adresse : 9 Rue de L'Eperon 75006 PARIS
  • Dirigeant : Denis, CAYET

Juridique

  • Forme juridique : SAS
  • Capital : 10375
  • NAF : 7211Z
  • Creation date : 10/03/2014
  • Effectif : 4
  • Couverture géographique : Worldwide
Retour à l'annuaire